Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Indicators as Provided by the EPIC ClearView

NCT01476995 is registered in ClinicalTrials.gov with Epic Research & Diagnostics, Inc. as lead sponsor.

NCT NCT01476995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01476995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Indicators as Provided by the EPIC ClearView
Lead sponsor
Epic Research & Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
June 30, 2011
Enrollment
353 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute renal failure, alcoholic hepatitis, asthma, atrial fibrillation, bronchitis, celiac sprue, cholecystitis, cirrhosis, congestive heart failure, copd, coronary artery disease, crohn's disease, diabetes, diverticulitis, emphysema, hypertension, inflammatory bowel disease, irritable bowel syndrome, malabsorption disorders, pancreatitis, peptic ulcer disease, pneumonia, pyelonephritis, renal failure, steatohepatitis, ulcerative colitis, valvular heart disease, viral hepatitis